Evidence map›Paper›PMID 29342502›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2018

Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators.

Melissa J Mulla, Ingrid C Weel, Julie A Potter, Stefan M Gysler, Jane E Salmon, Maria T S Peraçoli, Carla V Rothlin, Lawrence W Chamley, Vikki M Abrahams

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. B Cell Tolerance and Obstetric Antiphospholipid Syndrome.Clinical reviews in allergy & immunology · 2025
    Review
  6. Article
  7. Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy.International journal of molecular sciences · 2024
    Review
  8. Article
  9. The pathogenesis of obstetric APS: a 2023 update.Clinical immunology (Orlando, Fla.) · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Insight of Autophagy in Spontaneous Miscarriage.International journal of biological sciences · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Melissa J MullaYale University, New Haven, Connecticut.
Ingrid C WeelYale University, New Haven, Connecticut, and São Paulo State University, São Paulo, Brazil.
Julie A PotterYale University, New Haven, Connecticut.
Stefan M GyslerYale University, New Haven, Connecticut.
Jane E SalmonHospital for Special Surgery, New York, New York.
Maria T S PeraçoliSão Paulo State University, São Paulo, Brazil.
Carla V RothlinYale University, New Haven, Connecticut.
Lawrence W ChamleyUniversity of Auckland, Auckland, New Zealand.
Vikki M AbrahamsYale University, New Haven, Connecticut.
Yale University · USUniversidade Estadual Paulista (Unesp) · BRHospital for Special Surgery · USUniversity of Auckland · NZ

Funding

Predictors of Pregnancy Outcome In SLE and APSR01AR049772 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI SALMON, JANE E · 2003 to 2012
$12.6M
TAM receptor tyrosine kinases in inflammatory boweldiseaseR01AI089824 · NIAID · YALE UNIVERSITY · PI ROTHLIN, CARLA · 2010 to 2018
$3.9M
An innate immune checkpoint in cancer immunotherapy.R01CA212376 · NCI · YALE UNIVERSITY · PI GHOSH, SOURAV, ROTHLIN, CARLA · 2017 to 2021
$3.1M
HSRD VA CDP 12-255NCI NIH HHS R01 CA212376NIAID NIH HHS R01 AI089824NIAMS NIH HHS R01 AR049772
6 · The paper itself

Abstract

objectiveWomen with antiphospholipid antibodies (aPL) are at risk for pregnancy complications associated with poor placentation and placental inflammation. Although these antibodies are heterogeneous, some anti-β

methodsHuman trophoblasts were not treated or were treated with anti-β

resultsAnti-β

conclusionBasal TAM receptor function and autophagy may serve to inhibit trophoblast TLR and inflammasome function, respectively. Impairment of TAM receptor signaling and autophagy by anti-β

Indexed as

Antibodies, AntiphospholipidCell LineFemaleHumansImmunosuppressive AgentsInflammasomesInflammationNLR Family, Pyrin Domain-Containing 3 ProteinPregnancyPregnancy Trimester, FirstSirolimusToll-Like Receptor 4TrophoblastsAntibodies, AntiphospholipidImmunosuppressive AgentsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanSirolimusTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID29342502
PMCPMC5984662
OpenAlexW2791480861

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.